Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis

Currently available rabies post‐exposure prophylaxis (PEP) for use in humans includes equine or human rabies immunoglobulins (RIG). The replacement of RIG with an equally or more potent and safer product is strongly encouraged due to the high costs and limited availability of existing RIG. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales: De Benedictis, Paola, Minola, Andrea, Rota Nodari, Elena, Aiello, Roberta, Zecchin, Barbara, Salomoni, Angela, Foglierini, Mathilde, Agatic, Gloria, Vanzetta, Fabrizia, Lavenir, Rachel, Lepelletier, Anthony, Bentley, Emma, Weiss, Robin, Cattoli, Giovanni, Capua, Ilaria, Sallusto, Federica, Wright, Edward, Lanzavecchia, Antonio, Bourhy, Hervé, Corti, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818751/
https://www.ncbi.nlm.nih.gov/pubmed/26992832
http://dx.doi.org/10.15252/emmm.201505986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818751/
https://www.ncbi.nlm.nih.gov/pubmed/26992832
http://dx.doi.org/10.15252/emmm.201505986

Ejemplares similares